Drugs that boost immunity are making lung cancer less deadly

About 3% of people diagnosed with non-small-cell lung cancer (NSCLC) have a mutation in the ALK gene. Ten years ago, the best treatment for people with this form of the cancer who are likely to be yo… [+13941 chars]